Select Page

Ophthalmic Research Institute of Australia (ORIA)

The Ophthalmic Research Institute of Australia (ORIA) is a not for profit organisation dedicated to promoting research into the causes of eye disease and the prevention of blindness. ORIA was founded in 1953 by a group of eye doctors concerned with the need to advance eye research in Australia. Since then, ORIA has distributed millions of dollars to advance eye research.

ORIA has a wide focus on supporting research into all major eye diseases, as opposed to focusing on a single eye disease.

Research grants are made available annually through ORIA’s available funds, which are sourced through bequests and donations from individuals and organisations.  A large proportion of these funds have come from people whose sight has been saved as a result of advances in eye care, and who wish to express their appreciation in a tangible way.

Research grants awarded each year have enabled many ophthalmologists and vision scientists working in university departments to improve the diagnosis and treatment of eye diseases through clinical research.

ORIA conforms to the highest corporate governance standards with its fully audited annual financial statements and reports publicly available.

ORIA is the research arm of the Royal Australian and New Zealand College of Ophthalmologists (RANZCO) whilst maintaining its own independent corporate structure.

For more information, please visit the ORIA website.

ORIA Annual Report 2018-2019

 

ORIA GRANTS 2019

NameTitleGrant
Amount
Dr Fred ChenAntisense oligonucleotide mediated
modulation of CNOT3 to treat RP11
Esme Anderson
$50,000
Dr Stuart KeelArtificial intelligence based screening
of eye diseases
ORIA New Investigator
$49,617
Prof Justine SmithDengue Virus Infection of Retinal
Pigment Epithelium
Richard and Ina Humbley
$49,954
Dr Vivek GuptaRexinoid and Retinoid X receptors
in glaucoma
Ivy May Stephenson
$49,967
Prof Robert CassonPhotobiomodulation for retinitis
pigmentosa
Hardie Anselmi
$49,800
Prof Alex HewittInvestigating the role of a novel
locus associated with the
development of Giant Cell Arteritis
R & L Lowe Grant
$49,846
Dr Elaine ChongDescemetorhexis for Fuchs’
Endothelial Dystrophy
ORIA grant
$49,898.60
Dr Guei-Sheung LiuSwitchable Gene Therapy for
Controlled Intervention in Neovascular
Blindness
ANZRS
$49,920
Dr Yuyi YouOptic nerve damage in neuromyolitis
optica spectrum disorder (NMOSD)
and multiple sclerosis (MS)
ORIA/RANZCO NSW Branch
$45,380
Prof Stephanie WatsonThe cellular mechanism of UV damage
to the corneal epithelium
ORIA Grant
$50,000
Dr WengOnn ChanA novel calpain antagonist in retinal
detachment
ORIA New Investigator
$47,500
Dr Mark HassallAAV gene therapy for ganglion cell
neuroprotection in glaucoma
ORIA New Investigator
$49,879.38
Dr Nilisha FernandoExamining the therapeutic potential
of microRNAs to regulate inflammasome
activation in retinal degenerations
ORIA New Investigator Grant
$49,977

Last updated: November 8, 2019

Get in Touch

Do you have any queries or comments about our website, our products or any  of our services?
RANZCO acknowledges our First Australians, the Traditional
Custodians of the land on which we live and work, and pays
respect to Elders past, present and emerging. Gadigal people
of the Eora Nation are the traditional custodians of the land
where the RANZCO head office is located.

Follow Us

RANZCO is a member of The Australian Council for International Development (ACFID) and is compliant with the ACFID code of conduct.